{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T07:50:48Z","timestamp":1794124248341,"version":"4.8.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Accurate preoperative nodal staging remains challenging in gallbladder cancer (GBC), and a substantial proportion of patients presumed to be clinically node-negative have nodal metastasis at surgery. This study aimed to quantify the burden of occult nodal disease (OND)\u2014defined as pathologic node-positive disease among clinically node-negative patients\u2014and to identify preoperative factors associated with OND.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients who underwent upfront curative-intent resection with regional lymphadenectomy for GBC were identified from an international multi-institutional database. Among patients staged as clinically node-negative (cN0) on preoperative imaging, multivariable logistic regression was used to identify preoperative predictors of OND. CA19-9 and the systemic immune-inflammation index (SII) were log-transformed for modeling\u00a0purposes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 187 patients, 142 (75.9%) were classified as cN0 preoperatively, among\u00a0whom 47 (33.1%) had OND on final pathology. On multivariable analysis, higher ln(SII) (odds ratio [OR] 1.69, 95% confidence interval [CI] 1.05\u20132.86), higher ln(CA19-9) (OR 1.30, 95% CI 1.12\u20131.53), and preoperative jaundice (OR 3.68, 95% CI 1.21\u201311.76) were independently associated with OND. The observed OND rate increased stepwise with the number of elevated preoperative markers (SII &gt; 890.2, CA19-9 &gt; 37 U\/mL, and jaundice): 17.1% with 0 markers, 44.8% with 1 marker, and 73.6% with 2\u20133 markers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>OND was present in approximately one-third of clinically node-negative GBC patients undergoing lymphadenectomy. Preoperative jaundice, elevated CA19-9, and elevated SII independently predicted OND and provided simple risk stratification. Incorporating these readily available markers into preoperative assessment may improve risk enrichment for OND and help guide additional staging and treatment sequencing.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1245\/s10434-026-19460-0","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T18:53:36Z","timestamp":1773773616000},"page":"5816-5825","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Occult Nodal Disease in Gallbladder Cancer: An International Multi-institutional Analysis and Preoperative Risk Stratification"],"prefix":"10.1245","volume":"33","author":[{"given":"Jun","family":"Kawashima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kizuki","family":"Yuza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Sahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Aucejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo P.","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Hugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Kitago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ruzzenente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Homma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itaru","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7994-9870","authenticated-orcid":false,"given":"Timothy M.","family":"Pawlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"issue":"6","key":"19460_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin."},{"issue":"6","key":"19460_CR2","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3322\/canjclin.51.6.349","volume":"51","author":"EC Lazcano-Ponce","year":"2001","unstructured":"Lazcano-Ponce EC, Miquel JF, Mu\u00f1oz N, et al. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin. 2001;51(6):349\u201364. https:\/\/doi.org\/10.3322\/canjclin.51.6.349.","journal-title":"CA Cancer J Clin."},{"issue":"4","key":"19460_CR3","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/cam4.1044","volume":"6","author":"R Rahman","year":"2017","unstructured":"Rahman R, Simoes EJ, Schmaltz C, Jackson CS, Ibdah JA. Trend analysis and survival of primary gallbladder cancer in the United States: a 1973\u20132009 population-based study. Cancer Med. 2017;6(4):874\u201380. https:\/\/doi.org\/10.1002\/cam4.1044.","journal-title":"Cancer Med."},{"issue":"7","key":"19460_CR4","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/jso.21141","volume":"98","author":"A Duffy","year":"2008","unstructured":"Duffy A, Capanu M, Abou-Alfa GK, et al. Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol. 2008;98(7):485\u20139. https:\/\/doi.org\/10.1002\/jso.21141.","journal-title":"J Surg Oncol."},{"issue":"3","key":"19460_CR5","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1245\/s10434-024-16492-2","volume":"32","author":"G Catalano","year":"2025","unstructured":"Catalano G, Alaimo L, Chatzipanagiotou OP, et al. Advantage of log odds of metastatic lymph nodes after curative-intent resection of gallbladder cancer. Ann Surg Oncol. 2025;32(3):1742\u201351. https:\/\/doi.org\/10.1245\/s10434-024-16492-2.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"19460_CR6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.asjsur.2021.05.005","volume":"45","author":"P Burasakarn","year":"2022","unstructured":"Burasakarn P, Thienhiran A, Hongjinda S, Fuengfoo P. The optimal extent of surgery in T2 gallbladder cancer and the need for hepatectomy: a meta-analysis. Asian J Surg. 2022;45(1):33\u20138. https:\/\/doi.org\/10.1016\/j.asjsur.2021.05.005.","journal-title":"Asian J Surg."},{"issue":"4","key":"19460_CR7","doi-asserted-by":"publisher","first-page":"e856","DOI":"10.1097\/SLA.0000000000005154","volume":"277","author":"EAJ de Savornin Lohman","year":"2023","unstructured":"de Savornin Lohman EAJ, de Bitter TJJ, Hannink G, et al. Development and external validation of a model to predict overall survival in patients with resected gallbladder cancer. Ann Surg. 2023;277(4):e856\u201363. https:\/\/doi.org\/10.1097\/SLA.0000000000005154.","journal-title":"Ann Surg."},{"issue":"14","key":"19460_CR8","doi-asserted-by":"publisher","first-page":"4201","DOI":"10.3390\/jcm13144201","volume":"13","author":"L Tirca","year":"2024","unstructured":"Tirca L, Savin C, Stroescu C, et al. Risk factors and prognostic factors in GBC. J Clin Med. 2024;13(14):4201. https:\/\/doi.org\/10.3390\/jcm13144201.","journal-title":"J Clin Med."},{"issue":"11","key":"19460_CR9","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.hpb.2024.07.411","volume":"26","author":"J Palepu","year":"2024","unstructured":"IHPBA-APHPBA International Study Group of Gallbladder Cancer, Palepu J, Endo I, et al. \u201cIHPBA-APHPBA clinical practice guidelines\u201d: international Delphi consensus recommendations for gallbladder cancer. HPB (Oxford). 2024;26(11):1311\u201326. https:\/\/doi.org\/10.1016\/j.hpb.2024.07.411.","journal-title":"HPB (Oxford)."},{"issue":"5","key":"19460_CR10","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1007\/s00268-019-05365-5","volume":"44","author":"Y Moon","year":"2020","unstructured":"Moon Y, Choi SY, Park JK, Lee KY. Risk factors for occult lymph node metastasis in peripheral non-small cell lung cancer with invasive component size 3 cm or Less. World J Surg. 2020;44(5):1658\u201365. https:\/\/doi.org\/10.1007\/s00268-019-05365-5.","journal-title":"World J Surg."},{"issue":"2","key":"19460_CR11","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.clbc.2021.07.006","volume":"22","author":"JB Hammond","year":"2022","unstructured":"Hammond JB, Scott DW, Kosiorek HE, et al. Characterizing occult nodal disease within a clinically node-negative, neoadjuvant breast cancer population. Clin Breast Cancer. 2022;22(2):186\u201390. https:\/\/doi.org\/10.1016\/j.clbc.2021.07.006.","journal-title":"Clin Breast Cancer."},{"issue":"3","key":"19460_CR12","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.surg.2009.10.008","volume":"147","author":"N Wasif","year":"2010","unstructured":"Wasif N, Faries MB, Saha S, et al. Predictors of occult nodal metastasis in colon cancer: results from a prospective multicenter trial. Surgery. 2010;147(3):352\u20137. https:\/\/doi.org\/10.1016\/j.surg.2009.10.008.","journal-title":"Surgery."},{"issue":"4","key":"19460_CR13","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1245\/s10434-017-6290-8","volume":"25","author":"CM Court","year":"2018","unstructured":"Court CM, Ankeny JS, Sho S, et al. Circulating tumor cells predict occult metastatic disease and prognosis in pancreatic cancer. Ann Surg Oncol. 2018;25(4):1000\u20138. https:\/\/doi.org\/10.1245\/s10434-017-6290-8.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"19460_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jhep.2006.03.009","volume":"45","author":"H Petrowsky","year":"2006","unstructured":"Petrowsky H, Wildbrett P, Husarik DB, et al. Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma. J Hepatol. 2006;45(1):43\u201350. https:\/\/doi.org\/10.1016\/j.jhep.2006.03.009.","journal-title":"J Hepatol."},{"key":"19460_CR15","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ejrad.2018.11.034","volume":"110","author":"EAJ de Savornin Lohman","year":"2019","unstructured":"de Savornin Lohman EAJ, de Bitter TJJ, van Laarhoven CJHM, Hermans JJ, de Haas RJ, de Reuver PR. The diagnostic accuracy of CT and MRI for the detection of lymph node metastases in gallbladder cancer: A systematic review and meta-analysis. Eur J Radiol. 2019;110:156\u201362. https:\/\/doi.org\/10.1016\/j.ejrad.2018.11.034.","journal-title":"Eur J Radiol."},{"issue":"7","key":"19460_CR16","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1001\/archsurg.138.7.741","volume":"138","author":"N Kokudo","year":"2003","unstructured":"Kokudo N, Makuuchi M, Natori T, et al. Strategies for surgical treatment of gallbladder carcinoma based on information available before resection. Arch Surg. 2003;138(7):741\u201350. https:\/\/doi.org\/10.1001\/archsurg.138.7.741.","journal-title":"Arch Surg."},{"issue":"5","key":"19460_CR17","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.hpb.2025.01.006","volume":"27","author":"J Kawashima","year":"2025","unstructured":"Kawashima J, Endo Y, Woldesenbet S, et al. \u201cBiological R2\u201d resection for intrahepatic cholangiocarcinoma: identification of patients at risk for poor oncologic outcomes after curative-intent resection. HPB (Oxford). 2025;27(5):619\u201329. https:\/\/doi.org\/10.1016\/j.hpb.2025.01.006.","journal-title":"HPB (Oxford)."},{"issue":"4","key":"19460_CR18","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1245\/s10434-017-6025-x","volume":"25","author":"YS Chun","year":"2018","unstructured":"Chun YS, Pawlik TM, Vauthey JN. 8th Edition of the AJCC cancer staging manual: pancreas and hepatobiliary cancers. Ann Surg Oncol. 2018;25(4):845\u20137. https:\/\/doi.org\/10.1245\/s10434-017-6025-x.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"19460_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/jhbp.515","volume":"25","author":"M Yokoe","year":"2018","unstructured":"Yokoe M, Hata J, Takada T, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos). J Hepatobiliary Pancreat Sci. 2018;25(1):41\u201354. https:\/\/doi.org\/10.1002\/jhbp.515.","journal-title":"J Hepatobiliary Pancreat Sci."},{"issue":"12","key":"19460_CR20","doi-asserted-by":"publisher","first-page":"7605","DOI":"10.1245\/s10434-022-12058-2","volume":"29","author":"J Toyoda","year":"2022","unstructured":"Toyoda J, Sahara K, Maithel SK, et al. Prognostic utility of systemic immune-inflammation index after resection of extrahepatic cholangiocarcinoma: Results from the U.S. extrahepatic biliary malignancy consortium. Ann Surg Oncol. 2022;29(12):7605\u201314. https:\/\/doi.org\/10.1245\/s10434-022-12058-2.","journal-title":"Ann Surg Oncol."},{"issue":"6","key":"19460_CR21","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1245\/s10434-018-6444-3","volume":"25","author":"T Mochizuki","year":"2018","unstructured":"Mochizuki T, Abe T, Amano H, et al. Efficacy of the gallbladder cancer predictive risk score based on pathological findings: a propensity score-matched analysis. Ann Surg Oncol. 2018;25(6):1699\u2013708. https:\/\/doi.org\/10.1245\/s10434-018-6444-3.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"19460_CR22","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205\u201313. https:\/\/doi.org\/10.1097\/01.sla.0000133083.54934.ae.","journal-title":"Ann Surg."},{"issue":"6","key":"19460_CR23","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/(sici)1097-0258(19990330)18:6<681::aid-sim71>3.0.co;2-r","volume":"18","author":"S van Buuren","year":"1999","unstructured":"van Buuren S, Boshuizen HC, Knook DL. Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med. 1999;18(6):681\u201394. https:\/\/doi.org\/10.1002\/(sici)1097-0258(19990330)18:6%3c681::aid-sim71%3e3.0.co;2-r.","journal-title":"Stat Med."},{"issue":"2","key":"19460_CR24","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1477-2574.2009.00149.x","volume":"12","author":"I Hatzaras","year":"2010","unstructured":"Hatzaras I, Schmidt C, Muscarella P, Melvin WS, Ellison EC, Bloomston M. Elevated CA19-9 portends poor prognosis in patients undergoing resection of biliary malignancies. HPB (Oxford). 2010;12(2):134\u20138. https:\/\/doi.org\/10.1111\/j.1477-2574.2009.00149.x.","journal-title":"HPB (Oxford)."},{"key":"19460_CR25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.suronc.2019.09.006","volume":"31","author":"EE Montalvo-Jave","year":"2019","unstructured":"Montalvo-Jave EE, Rahnemai-Azar AA, Papaconstantinou D, et al. Molecular pathways and potential biomarkers in gallbladder cancer: A comprehensive review. Surg Oncol. 2019;31:83\u20139. https:\/\/doi.org\/10.1016\/j.suronc.2019.09.006.","journal-title":"Surg Oncol."},{"issue":"14","key":"19460_CR26","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.3748\/wjg.v20.i14.4085","volume":"20","author":"YF Wang","year":"2014","unstructured":"Wang YF, Feng FL, Zhao XH, et al. Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer. World J Gastroenterol. 2014;20(14):4085\u201392. https:\/\/doi.org\/10.3748\/wjg.v20.i14.4085.","journal-title":"World J Gastroenterol."},{"issue":"8","key":"19460_CR27","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s11605-017-3440-z","volume":"21","author":"TB Tran","year":"2017","unstructured":"Tran TB, Norton JA, Ethun CG, et al. Gallbladder cancer presenting with jaundice: uniformly fatal or still potentially curable? J Gastrointest Surg. 2017;21(8):1245\u201353. https:\/\/doi.org\/10.1007\/s11605-017-3440-z.","journal-title":"J Gastrointest Surg."},{"issue":"3","key":"19460_CR28","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/jso.25186","volume":"118","author":"BVM Dasari","year":"2018","unstructured":"Dasari BVM, Ionescu MI, Pawlik TM, et al. Outcomes of surgical resection of gallbladder cancer in patients presenting with jaundice: A systematic review and meta-analysis. J Surg Oncol. 2018;118(3):477\u201385. https:\/\/doi.org\/10.1002\/jso.25186.","journal-title":"J Surg Oncol."},{"issue":"7203","key":"19460_CR29","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436\u201344. https:\/\/doi.org\/10.1038\/nature07205.","journal-title":"Nature."},{"issue":"6917","key":"19460_CR30","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860\u20137. https:\/\/doi.org\/10.1038\/nature01322.","journal-title":"Nature."},{"key":"19460_CR31","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/0-387-26283-0_5","volume":"130","author":"TL Whiteside","year":"2006","unstructured":"Whiteside TL. The role of immune cells in the tumor microenvironment. Cancer Treat Res. 2006;130:103\u201324. https:\/\/doi.org\/10.1007\/0-387-26283-0_5.","journal-title":"Cancer Treat Res."},{"issue":"1","key":"19460_CR32","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.gassur.2023.10.002","volume":"28","author":"J Kawashima","year":"2024","unstructured":"Kawashima J, Sahara K, Shen F, et al. Predicting risk of recurrence after resection of stage I intrahepatic cholangiocarcinoma. J Gastrointest Surg. 2024;28(1):18\u201325. https:\/\/doi.org\/10.1016\/j.gassur.2023.10.002.","journal-title":"J Gastrointest Surg."},{"issue":"12","key":"19460_CR33","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/j.hpb.2020.03.011","volume":"22","author":"DI Tsilimigras","year":"2020","unstructured":"Tsilimigras DI, Moris D, Mehta R, et al. The systemic immune-inflammation index predicts prognosis in intrahepatic cholangiocarcinoma: an international multi-institutional analysis. HPB (Oxford). 2020;22(12):1667\u201374. https:\/\/doi.org\/10.1016\/j.hpb.2020.03.011.","journal-title":"HPB (Oxford)."},{"issue":"12","key":"19460_CR34","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1007\/s00011-024-01959-5","volume":"73","author":"W Li","year":"2024","unstructured":"Li W, Wang X, Diao H, et al. Systemic immune inflammation index with all-cause and cause-specific mortality: a meta-analysis. Inflamm Res. 2024;73(12):2199\u2013216. https:\/\/doi.org\/10.1007\/s00011-024-01959-5.","journal-title":"Inflamm Res."},{"issue":"9","key":"19460_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2025.110267","volume":"51","author":"Z Huang","year":"2025","unstructured":"Huang Z, Wang J, Zhou B, et al. Application of systemic immune-inflammation index in survival prediction after radical resection of gallbladder cancer: a multicenter retrospective clinical study. Eur J Surg Oncol. 2025;51(9):110267. https:\/\/doi.org\/10.1016\/j.ejso.2025.110267.","journal-title":"Eur J Surg Oncol."},{"key":"19460_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.554521","volume":"10","author":"L Sun","year":"2020","unstructured":"Sun L, Jin Y, Hu W, et al. The impacts of systemic immune-inflammation index on clinical outcomes in gallbladder carcinoma. Front Oncol. 2020;10:554521. https:\/\/doi.org\/10.3389\/fonc.2020.554521.","journal-title":"Front Oncol."},{"issue":"10","key":"19460_CR37","doi-asserted-by":"publisher","first-page":"7152","DOI":"10.1245\/s10434-025-17781-0","volume":"32","author":"J Kawashima","year":"2025","unstructured":"Kawashima J, Akabane M, Khalil M, et al. Preoperative systemic immune-inflammatory index predicts occult nodal disease in clinically node-negative intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2025;32(10):7152\u201362. https:\/\/doi.org\/10.1245\/s10434-025-17781-0.","journal-title":"Ann Surg Oncol."},{"key":"19460_CR38","doi-asserted-by":"publisher","DOI":"10.1097\/XCS.0000000000001244","author":"AA Khan","year":"2024","unstructured":"Khan AA, Shah SK, Basu S, Alex GC, Liptay MJ, Geissen NM, et al. Increased systemic immune-inflammatory index and association with occult nodal disease in non-small cell lung cancer. J Am Coll Surg. 2024. https:\/\/doi.org\/10.1097\/XCS.0000000000001244.","journal-title":"J Am Coll Surg"},{"key":"19460_CR39","doi-asserted-by":"publisher","first-page":"7131","DOI":"10.2147\/JIR.S345790","volume":"14","author":"H Lei","year":"2021","unstructured":"Lei H, Xu S, Mao X, Chen X, Chen Y, Sun X, et al. Systemic immune-inflammatory index as a predictor of lymph node metastasis in endometrial cancer. J Inflamm Res. 2021;14:7131\u201342. https:\/\/doi.org\/10.2147\/JIR.S345790.","journal-title":"J Inflamm Res."},{"issue":"11","key":"19460_CR40","doi-asserted-by":"publisher","first-page":"znae297","DOI":"10.1093\/bjs\/znae297","volume":"111","author":"G Catalano","year":"2024","unstructured":"Catalano G, Alaimo L, Chatzipanagiotou OP, et al. Machine learning prediction of early recurrence after surgery for gallbladder cancer. Br J Surg. 2024;111(11):znae297. https:\/\/doi.org\/10.1093\/bjs\/znae297.","journal-title":"Br J Surg."},{"issue":"21","key":"19460_CR41","doi-asserted-by":"publisher","first-page":"7545","DOI":"10.3390\/jcm14217545","volume":"14","author":"DM de Jong","year":"2025","unstructured":"de Jong DM, van Driel LMJW, Lakhtakia S, et al. Endoscopic ultrasound for nodal staging in patients with resectable cholangiocarcinoma. J Clin Med. 2025;14(21):7545. https:\/\/doi.org\/10.3390\/jcm14217545.","journal-title":"J Clin Med."},{"issue":"2","key":"19460_CR42","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/den.14576","volume":"36","author":"Y Kuraishi","year":"2024","unstructured":"Kuraishi Y, Hara K, Haba S, et al. Diagnostic performance and safety of endoscopic ultrasound-guided fine-needle aspiration\/biopsy for gallbladder lesions. Dig Endosc. 2024;36(2):206\u201314. https:\/\/doi.org\/10.1111\/den.14576.","journal-title":"Dig Endosc."},{"issue":"1","key":"19460_CR43","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1038\/s41598-025-87473-y","volume":"15","author":"K Sato","year":"2025","unstructured":"Sato K, Shigekawa M, Yamamoto S, et al. Utility and clinical significance of endoscopic ultrasound-guided tissue acquisition for diagnosing lymphadenopathies in biliary tract cancer. Sci Rep. 2025;15(1):3363. https:\/\/doi.org\/10.1038\/s41598-025-87473-y.","journal-title":"Sci Rep."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19460-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-19460-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19460-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:27:38Z","timestamp":1778869658000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-19460-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["19460"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-19460-0","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"12 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}